162 related articles for article (PubMed ID: 11119616)
1. Functional and selective targeting of adenovirus to high-affinity Fcgamma receptor I-positive cells by using a bispecific hybrid adapter.
Ebbinghaus C; Al-Jaibaji A; Operschall E; Schöffel A; Peter I; Greber UF; Hemmi S
J Virol; 2001 Jan; 75(1):480-9. PubMed ID: 11119616
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus targeting to c-erbB-2 oncoprotein by single-chain antibody fused to trimeric form of adenovirus receptor ectodomain.
Kashentseva EA; Seki T; Curiel DT; Dmitriev IP
Cancer Res; 2002 Jan; 62(2):609-16. PubMed ID: 11809717
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells.
Pereboev AV; Asiedu CK; Kawakami Y; Dong SS; Blackwell JL; Kashentseva EA; Triozzi PL; Aldrich WA; Curiel DT; Thomas JM; Dmitriev IP
Gene Ther; 2002 Sep; 9(17):1189-93. PubMed ID: 12170383
[TBL] [Abstract][Full Text] [Related]
5. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.
Mizuguchi H; Koizumi N; Hosono T; Utoguchi N; Watanabe Y; Kay MA; Hayakawa T
Gene Ther; 2001 May; 8(9):730-5. PubMed ID: 11406768
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
[TBL] [Abstract][Full Text] [Related]
7. Positive and negative regulation of adenovirus infection by CAR-like soluble protein, CLSP.
Kawabata K; Tashiro K; Sakurai F; Osada N; Kusuda J; Hayakawa T; Yamanishi K; Mizuguchi H
Gene Ther; 2007 Aug; 14(16):1199-207. PubMed ID: 17538635
[TBL] [Abstract][Full Text] [Related]
8. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.
Kaner RJ; Worgall S; Leopold PL; Stolze E; Milano E; Hidaka C; Ramalingam R; Hackett NR; Singh R; Bergelson J; Finberg R; Falck-Pedersen E; Crystal RG
Am J Respir Cell Mol Biol; 1999 Mar; 20(3):361-70. PubMed ID: 10030833
[TBL] [Abstract][Full Text] [Related]
9. Design and expression of polymeric immunoglobulin fusion proteins: a strategy for targeting low-affinity Fcgamma receptors.
White DM; Jensen MA; Shi X; Qu Zx ; Arnason BG
Protein Expr Purif; 2001 Apr; 21(3):446-55. PubMed ID: 11281720
[TBL] [Abstract][Full Text] [Related]
10. Selectivity of TAG-72-targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro.
Kelly FJ; Miller CR; Buchsbaum DJ; Gomez-Navarro J; Barnes MN; Alvarez RD; Curiel DT
Clin Cancer Res; 2000 Nov; 6(11):4323-33. PubMed ID: 11106250
[TBL] [Abstract][Full Text] [Related]
11. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
[TBL] [Abstract][Full Text] [Related]
12. Biophysical targeting of adenovirus vectors for gene therapy.
Silman NJ; Fooks AR
Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
[TBL] [Abstract][Full Text] [Related]
13. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
[TBL] [Abstract][Full Text] [Related]
14. Altered tropism of an ovine adenovirus carrying the fiber protein cell binding domain of human adenovirus type 5.
Xu ZZ; Both GW
Virology; 1998 Aug; 248(1):156-63. PubMed ID: 9705265
[TBL] [Abstract][Full Text] [Related]
15. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
16. Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells.
McDonald D; Stockwin L; Matzow T; Blair Zajdel ME; Blair GE
Gene Ther; 1999 Sep; 6(9):1512-9. PubMed ID: 10490760
[TBL] [Abstract][Full Text] [Related]
17. Free cholesterol enhances adenoviral vector gene transfer and expression in CAR-deficient cells.
Worgall S; Worgall TS; Kostarelos K; Singh R; Leopold PL; Hackett NR; Crystal RG
Mol Ther; 2000 Jan; 1(1):39-48. PubMed ID: 10933910
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
[TBL] [Abstract][Full Text] [Related]
19. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
[TBL] [Abstract][Full Text] [Related]
20. hCAR-EGFP fusion receptor in human follicular lymphoma B cells - a model for adenoviral gene therapy for B cell malignancies.
Mättö M; Nuutinen UM; Hakkarainen T; Tallone T; Wahlfors J; Pelkonen J
Int J Mol Med; 2006 Jun; 17(6):1057-62. PubMed ID: 16685416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
